» Articles » PMID: 27291461

A Bioprinted Liver-on-a-Chip for Drug Screening Applications

Overview
Specialty Biochemistry
Date 2016 Jun 14
PMID 27291461
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The need for a liver-on-a-chip tissue model for drug screening is particularly important in tissue engineering because of the high frequency of drug-induced liver injury. Recently, a liver tissue model conducive to hepatotoxicity testing was developed by bioprinting hepatic spheroids encapsulated in a hydrogel scaffold into a microfluidic device.

Citing Articles

Recent advances in liver-on-chips: Design, fabrication, and applications.

Qiu L, Kong B, Kong T, Wang H Smart Med. 2024; 2(1):e20220010.

PMID: 39188562 PMC: 11235950. DOI: 10.1002/SMMD.20220010.


Grand challenges in organoid and organ-on-a-chip technologies.

Skardal A Front Bioeng Biotechnol. 2024; 12:1366280.

PMID: 38456004 PMC: 10919399. DOI: 10.3389/fbioe.2024.1366280.


Microphysiological systems for human aging research.

Park S, Laskow T, Chen J, Guha P, Dawn B, Kim D Aging Cell. 2024; 23(3):e14070.

PMID: 38180277 PMC: 10928588. DOI: 10.1111/acel.14070.


Emerging trends in organ-on-a-chip systems for drug screening.

Wang Y, Gao Y, Pan Y, Zhou D, Liu Y, Yin Y Acta Pharm Sin B. 2023; 13(6):2483-2509.

PMID: 37425038 PMC: 10326261. DOI: 10.1016/j.apsb.2023.02.006.


Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system.

Wang P, Jin L, Zhang M, Wu Y, Duan Z, Guo Y Nat Biomed Eng. 2023; 8(8):1053-1068.

PMID: 37349391 DOI: 10.1038/s41551-023-01054-w.